
|Articles|February 1, 1997
Supplements and Featured Publications
- Looking Beyond the Formulary Budget: Cost Analysis and a Psychiatric Perspective
- Volume 3
- Issue 2 Suppl
Looking Beyond the Formulary Budget in Cost-Benefit Analysis
Author(s)Lawrence J. Cohen, PharmD
Advertisement
Articles in this issue
about 29 years ago
Introduction: Looking Beyond the Formulary Budgetabout 29 years ago
Evaluating the Cost Effectiveness of Newer Psychotropic Medicationsabout 29 years ago
Retrospective Analysis of the Effect of Risperidone on Clinical Outcomeabout 29 years ago
Newer Antipsychotic Medications: Discussionsabout 29 years ago
Bibliographyabout 29 years ago
ParticipantsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
New Legislation Aims to Address Transparency in PBMs as First Major Step in Reform
2
Advances in MASLD and MASH Care Highlight Progress and Persistent Gaps
3
Catchment Areas Shape Diversity and Access in Oncology Trials: Amir Fathi, MD
4
Overcoming Mistrust in Clinical Trial Enrollment Through Community Resources: Susan Vadaparampil, PhD, MPH
5
















